Roche signs strategic collaboration and licence agreement with Roche

By PBR Staff Writer

Shape Therapeutics has entered into a multi-target strategic collaboration and licence agreement with Roche to develop gene therapy for particular targets in the areas of Alzheimer’s disease, Parkinson’s disease, and rare diseases.